Better Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Better Therapeutics

13/05/2023 24:04

* Better Therapeutics Inc  BTTX.OQ  reported a quarterly
adjusted
loss of 39 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 74 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Better Therapeutics Inc's reported EPS for the quarter was
a
loss of 39 cents​.
    * The mean earnings estimate of analysts had risen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Better Therapeutics Inc shares had risen by 12.1% this
quarter and lost 29.0% so far this year.
    * The company reported a quarterly loss of $9.36 million.
    * Wall Street's median 12-month price target for Better
Therapeutics Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
12 at 11:04 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.74          -0.39          Beat
 Dec. 31 2022      -0.51          -0.37          Beat
 Sep. 30 2022      -0.48          -0.48          Met
 Jun. 30 2022      -0.45          -0.42          Beat